DRIEHAUS CAPITAL MANAGEMENT LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DRIEHAUS CAPITAL MANAGEMENT LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$54,799,932
-43.9%
1,000,912
-13.9%
0.71%
-42.2%
Q2 2023$97,602,732
+20.2%
1,162,214
+8.4%
1.23%
+8.1%
Q1 2023$81,197,024
+19.4%
1,072,191
-2.6%
1.14%
+12.5%
Q4 2022$67,976,988
+63.4%
1,101,377
+10.5%
1.01%
+60.8%
Q3 2022$41,597,000
+115.1%
996,569
+62.1%
0.63%
+101.3%
Q2 2022$19,338,000614,8810.31%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders